Evidence map›Paper›PMID 35579753›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily care.

Diego Muñoz-Guglielmetti, Tim Cooksley, Shin Ahn, Carmen Beato, Mario Aramberri, Carmen Escalante, Carme Font, Multinational Association of Supportive Care in Cancer (MASCC) Hemostasis Study Group

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diego Muñoz-GuglielmettiRadiation Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1857-8930
Tim CooksleyThe Christie Hospital, University of Manchester, Wythenshawe Hospital, Manchester, UK.ORCID http://orcid.org/0000-0001-6114-1956
Shin AhnDepartment of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0001-8642-6552
Carmen BeatoMedical Oncology Department, Hospital Universitario Macarena, Seville, Spain.ORCID http://orcid.org/0000-0002-1349-2652
Mario AramberriInternal Medicine Department, Hospital Galdakao-Usansolo, Vizcaya, Spain.ORCID http://orcid.org/0000-0001-7002-2852
Carmen EscalanteInternal Medicine Department, MD Anderson Cancer Center, University of Texas, Houston, USA.ORCID http://orcid.org/0000-0003-4287-7823
Carme FontMedical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. CFONT@clinic.cat.ORCID http://orcid.org/0000-0002-3547-7373
Multinational Association of Supportive Care in Cancer (MASCC) Hemostasis Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary embolism (PE) is a leading cause of morbidity and mortality in patients with cancer. The clinical presentation and outcomes of PE range from an acute life-threatening condition requiring intensive care to a mild symptomatic condition associated with favorable outcomes and potentially candidate for early hospital discharge. The wide clinical spectrum of PE has led to the development of risk stratification models aimed at the triage of patients in emergency care departments and optimizing the utilization of health care resources. Incidental or unsuspected PE (UPE), detected during routine staging computed tomography scans, make up a significant proportion of this cohort among the oncology population. The present narrative review is aimed at examining the currently available PE risk assessment models developed for the general population and for patients with cancer including UPE. We include general recommendations for the daily care of patients with cancer-related PE and hypothesize on the factors that would potentially favor hospitalization with early discharge or ambulatory management in this setting.

Indexed as

NeoplasmsPulmonary EmbolismAcute DiseaseCohort StudiesHospitalizationHumansRisk AssessmentAcute pulmonary embolismCancer-associated venous thromboembolismSupportive care oncologyUnsuspected pulmonary embolism

Identifiers

PMID35579753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.